Global COVID-19 Medicine Market Research Report 2020

Publisher Name :
Date: 01-May-2020
No. of pages: 128
Inquire Before Buying

This report focuses on the global COVID-19 Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Advanz Pharma

- Kyung Poong

- Mylan

- Novartis

- Sanofi

- Apotex

- Bayer

- Guangzhou Baiyunshan Guanghua Pharmaceutical

- Ipca Laboratories

- Sichuan Sunny Hope

- Zydus Cadila

- Teva

- Sun Pharma

- Rising Pharmaceutical

- KPC Group

- Bristol Laboratories

- Shanghai Zhongxisanwei

- Shanghai Pharma

Market segment by Type, the product can be split into

- Tablet

- Injection

Market segment by Application, split into

- Patients With Mild Symptoms

- Critically Ill

- Other

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global COVID-19 Medicine status, future forecast, growth opportunity, key market and key players.

- To present the COVID-19 Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of COVID-19 Medicine are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global COVID-19 Medicine Market Research Report 2020

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global COVID-19 Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tablet
1.4.3 Injection
1.5 Market by Application
1.5.1 Global COVID-19 Medicine Market Share by Application: 2020 VS 2026
1.5.2 Patients With Mild Symptoms
1.5.3 Critically Ill
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the COVID-19 Medicine Industry
1.6.1.1 COVID-19 Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COVID-19 Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COVID-19 Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 COVID-19 Medicine Market Perspective (2015-2026)
2.2 COVID-19 Medicine Growth Trends by Regions
2.2.1 COVID-19 Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Medicine Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Competition Landscape by Key Players
3.1 COVID-19 Medicine Revenue by Players (2019-2020)
3.2 COVID-19 Medicine Key Players Head office and Area Served
3.3 Key Players COVID-19 Medicine Product/Solution/Service
3.4 Date of Enter into COVID-19 Medicine Market
3.5 Key Players COVID-19 Medicine Funding/Investment Analysis
3.6 Global Key Players COVID-19 Medicine Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans
4 Global COVID-19 Medicine Market Size by Type (2019-2026)
5 Global COVID-19 Medicine Market Size by Application (2019-2026)
6 North America
6.1 North America COVID-19 Medicine Market Forecast (2019-2026)
6.2 COVID-19 Medicine Key Players in North America (2019-2020)
6.3 North America COVID-19 Medicine Market Size by Type (2015-2020)
6.4 North America COVID-19 Medicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe COVID-19 Medicine Market Forecast (2019-2026)
7.2 COVID-19 Medicine Key Players in Europe (2019-2020)
7.3 Europe COVID-19 Medicine Market Size by Type (2015-2020)
7.4 Europe COVID-19 Medicine Market Size by Application (2015-2020)
8 China
8.1 China COVID-19 Medicine Market Forecast (2019-2026)
8.2 COVID-19 Medicine Key Players in China (2019-2020)
8.3 China COVID-19 Medicine Market Size by Type (2015-2020)
8.4 China COVID-19 Medicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan COVID-19 Medicine Market Forecast (2019-2026)
9.2 COVID-19 Medicine Key Players in Japan (2019-2020)
9.3 Japan COVID-19 Medicine Market Size by Type (2015-2020)
9.4 Japan COVID-19 Medicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia COVID-19 Medicine Market Forecast (2019-2026)
10.2 COVID-19 Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COVID-19 Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia COVID-19 Medicine Market Size by Application (2015-2020)
11 India
11.1 India COVID-19 Medicine Market Forecast (2019-2026)
11.2 COVID-19 Medicine Key Players in India (2019-2020)
11.3 India COVID-19 Medicine Market Size by Type (2015-2020)
11.4 India COVID-19 Medicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America COVID-19 Medicine Market Forecast (2019-2026)
12.2 COVID-19 Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America COVID-19 Medicine Market Size by Type (2015-2020)
12.4 Central & South America COVID-19 Medicine Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Advanz Pharma
13.1.1 Advanz Pharma Company Details
13.1.2 Advanz Pharma Business Overview and Its Total Revenue
13.1.3 Advanz Pharma COVID-19 Medicine Introduction
13.1.4 Advanz Pharma Revenue in COVID-19 Medicine Business (2019-2020))
13.1.5 Advanz Pharma Recent Development
13.2 Kyung Poong
13.2.1 Kyung Poong Company Details
13.2.2 Kyung Poong Business Overview and Its Total Revenue
13.2.3 Kyung Poong COVID-19 Medicine Introduction
13.2.4 Kyung Poong Revenue in COVID-19 Medicine Business (2019-2020))
13.2.5 Kyung Poong Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview and Its Total Revenue
13.3.3 Mylan COVID-19 Medicine Introduction
13.3.4 Mylan Revenue in COVID-19 Medicine Business (2019-2020))
13.3.5 Mylan Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis COVID-19 Medicine Introduction
13.4.4 Novartis Revenue in COVID-19 Medicine Business (2019-2020))
13.4.5 Novartis Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview and Its Total Revenue
13.5.3 Sanofi COVID-19 Medicine Introduction
13.5.4 Sanofi Revenue in COVID-19 Medicine Business (2019-2020))
13.5.5 Sanofi Recent Development
13.6 Apotex
13.6.1 Apotex Company Details
13.6.2 Apotex Business Overview and Its Total Revenue
13.6.3 Apotex COVID-19 Medicine Introduction
13.6.4 Apotex Revenue in COVID-19 Medicine Business (2019-2020))
13.6.5 Apotex Recent Development
13.7 Bayer
13.7.1 Bayer Company Details
13.7.2 Bayer Business Overview and Its Total Revenue
13.7.3 Bayer COVID-19 Medicine Introduction
13.7.4 Bayer Revenue in COVID-19 Medicine Business (2019-2020))
13.7.5 Bayer Recent Development
13.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
13.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
13.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview and Its Total Revenue
13.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Introduction
13.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business (2019-2020))
13.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
13.9 Ipca Laboratories
13.9.1 Ipca Laboratories Company Details
13.9.2 Ipca Laboratories Business Overview and Its Total Revenue
13.9.3 Ipca Laboratories COVID-19 Medicine Introduction
13.9.4 Ipca Laboratories Revenue in COVID-19 Medicine Business (2019-2020))
13.9.5 Ipca Laboratories Recent Development
13.10 Sichuan Sunny Hope
13.10.1 Sichuan Sunny Hope Company Details
13.10.2 Sichuan Sunny Hope Business Overview and Its Total Revenue
13.10.3 Sichuan Sunny Hope COVID-19 Medicine Introduction
13.10.4 Sichuan Sunny Hope Revenue in COVID-19 Medicine Business (2019-2020))
13.10.5 Sichuan Sunny Hope Recent Development
13.11 Zydus Cadila
10.11.1 Zydus Cadila Company Details
10.11.2 Zydus Cadila Business Overview and Its Total Revenue
10.11.3 Zydus Cadila COVID-19 Medicine Introduction
10.11.4 Zydus Cadila Revenue in COVID-19 Medicine Business (2019-2020))
10.11.5 Zydus Cadila Recent Development
13.12 Teva
10.12.1 Teva Company Details
10.12.2 Teva Business Overview and Its Total Revenue
10.12.3 Teva COVID-19 Medicine Introduction
10.12.4 Teva Revenue in COVID-19 Medicine Business (2019-2020))
10.12.5 Teva Recent Development
13.13 Sun Pharma
10.13.1 Sun Pharma Company Details
10.13.2 Sun Pharma Business Overview and Its Total Revenue
10.13.3 Sun Pharma COVID-19 Medicine Introduction
10.13.4 Sun Pharma Revenue in COVID-19 Medicine Business (2019-2020))
10.13.5 Sun Pharma Recent Development
13.14 Rising Pharmaceutical
10.14.1 Rising Pharmaceutical Company Details
10.14.2 Rising Pharmaceutical Business Overview and Its Total Revenue
10.14.3 Rising Pharmaceutical COVID-19 Medicine Introduction
10.14.4 Rising Pharmaceutical Revenue in COVID-19 Medicine Business (2019-2020))
10.14.5 Rising Pharmaceutical Recent Development
13.15 KPC Group
10.15.1 KPC Group Company Details
10.15.2 KPC Group Business Overview and Its Total Revenue
10.15.3 KPC Group COVID-19 Medicine Introduction
10.15.4 KPC Group Revenue in COVID-19 Medicine Business (2019-2020))
10.15.5 KPC Group Recent Development
13.16 Bristol Laboratories
10.16.1 Bristol Laboratories Company Details
10.16.2 Bristol Laboratories Business Overview and Its Total Revenue
10.16.3 Bristol Laboratories COVID-19 Medicine Introduction
10.16.4 Bristol Laboratories Revenue in COVID-19 Medicine Business (2019-2020))
10.16.5 Bristol Laboratories Recent Development
13.17 Shanghai Zhongxisanwei
10.17.1 Shanghai Zhongxisanwei Company Details
10.17.2 Shanghai Zhongxisanwei Business Overview and Its Total Revenue
10.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Introduction
10.17.4 Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business (2019-2020))
10.17.5 Shanghai Zhongxisanwei Recent Development
13.18 Shanghai Pharma
10.18.1 Shanghai Pharma Company Details
10.18.2 Shanghai Pharma Business Overview and Its Total Revenue
10.18.3 Shanghai Pharma COVID-19 Medicine Introduction
10.18.4 Shanghai Pharma Revenue in COVID-19 Medicine Business (2019-2020))
10.18.5 Shanghai Pharma Recent Development
14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porter's Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis
15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. COVID-19 Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 Medicine Revenue
Table 3. Ranking of Global Top COVID-19 Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Injection
Table 7. COVID-19 Impact Global Market: (Four COVID-19 Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for COVID-19 Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for COVID-19 Medicine Players to Combat Covid-19 Impact
Table 12. Global COVID-19 Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global COVID-19 Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global COVID-19 Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 Medicine Market Share by Regions 2019-2026
Table 16. Market Top Trends
Table 17. Market Use Cases
Table 18. Global COVID-19 Medicine Revenue by Players (2019-2020) (Million US$)
Table 19. Global COVID-19 Medicine Market Share by Players (2019-2020)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COVID-19 Medicine Product Solution and Service
Table 22. Date of Enter into COVID-19 Medicine Market
Table 23. Global Key Players COVID-19 Medicine Funding/Investment Analysis (Million USD)
Table 24. Global Key Players COVID-19 Medicine Valuation & Market Capitalization (Million USD)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 27. Global COVID-19 Medicine Market Size Share by Type (2019-2026)
Table 28. Global COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 29. Global COVID-19 Medicine Market Size Share by Application (2019-2026)
Table 30. North America Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 31. North America Key Players COVID-19 Medicine Market Share (2019-2020)
Table 32. North America COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 33. North America COVID-19 Medicine Market Share by Type (2019-2026)
Table 34. North America COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 35. North America COVID-19 Medicine Market Share by Application (2019-2026)
Table 36. Europe Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 37. Europe Key Players COVID-19 Medicine Market Share (2019-2020)
Table 38. Europe COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 39. Europe COVID-19 Medicine Market Share by Type (2019-2026)
Table 40. Europe COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 41. Europe COVID-19 Medicine Market Share by Application (2019-2026)
Table 42. China Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 43. China Key Players COVID-19 Medicine Market Share (2019-2020)
Table 44. China COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 45. China COVID-19 Medicine Market Share by Type (2019-2026)
Table 46. China COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 47. China COVID-19 Medicine Market Share by Application (2019-2026)
Table 48. Japan Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 49. Japan Key Players COVID-19 Medicine Market Share (2019-2020)
Table 50. Japan COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 51. Japan COVID-19 Medicine Market Share by Type (2019-2026)
Table 52. Japan COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 53. Japan COVID-19 Medicine Market Share by Application (2019-2026)
Table 54. Southeast Asia Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 55. Southeast Asia Key Players COVID-19 Medicine Market Share (2019-2020)
Table 56. Southeast Asia COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 57. Southeast Asia COVID-19 Medicine Market Share by Type (2019-2026)
Table 58. Southeast Asia COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 59. Southeast Asia COVID-19 Medicine Market Share by Application (2019-2026)
Table 60. India Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 61. India Key Players COVID-19 Medicine Market Share (2019-2020)
Table 62. India COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 63. India COVID-19 Medicine Market Share by Type (2019-2026)
Table 64. India COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 65. India COVID-19 Medicine Market Share by Application (2019-2026)
Table 66. Central & South America Key Players COVID-19 Medicine Revenue (2019-2020) (Million US$)
Table 67. Central & South America Key Players COVID-19 Medicine Market Share (2019-2020)
Table 68. Central & South America COVID-19 Medicine Market Size by Type (2019-2026) (Million US$)
Table 69. Central & South America COVID-19 Medicine Market Share by Type (2019-2026)
Table 70. Central & South America COVID-19 Medicine Market Size by Application (2019-2026) (Million US$)
Table 71. Central & South America COVID-19 Medicine Market Share by Application (2019-2026)
Table 72. Advanz Pharma Company Details
Table 73. Advanz Pharma Business Overview
Table 74. Advanz Pharma Product
Table 75. Company Description and Business Overview
Table 76. Advanz Pharma COVID-19 Medicine Product
Table 77. Advanz Pharma Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 78. Advanz Pharma Recent Development
Table 79. Kyung Poong Company Details
Table 80. Kyung Poong Business Overview
Table 81. Kyung Poong Product
Table 82. Company Description and Business Overview
Table 83. Kyung Poong COVID-19 Medicine Product
Table 84. Kyung Poong Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 85. Kyung Poong Recent Development
Table 86. Mylan Company Details
Table 87. Mylan Business Overview
Table 88. Mylan Product
Table 89. Company Description and Business Overview
Table 90. Mylan COVID-19 Medicine Product
Table 91. Mylan Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 92. Mylan Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Product
Table 96. Company Description and Business Overview
Table 97. Novartis COVID-19 Medicine Product
Table 98. Novartis Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 99. Novartis Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Product
Table 103. Company Description and Business Overview
Table 104. Sanofi COVID-19 Medicine Product
Table 105. Sanofi Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 106. Sanofi Recent Development
Table 107. Apotex Company Details
Table 108. Apotex Business Overview
Table 109. Apotex Product
Table 110. Company Description and Business Overview
Table 111. Apotex COVID-19 Medicine Product
Table 112. Apotex Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 113. Apotex Recent Development
Table 114. Bayer Company Details
Table 115. Bayer Business Overview
Table 116. Bayer Product
Table 117. Company Description and Business Overview
Table 118. Bayer COVID-19 Medicine Product
Table 119. Bayer Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 120. Bayer Recent Development
Table 121. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
Table 122. Guangzhou Baiyunshan Guanghua Pharmaceutical Product
Table 123. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
Table 124. Company Description and Business Overview
Table 125. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product
Table 126. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 127. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
Table 128. Ipca Laboratories Company Details
Table 129. Ipca Laboratories Business Overview
Table 130. Ipca Laboratories Product
Table 131. Company Description and Business Overview
Table 132. Ipca Laboratories COVID-19 Medicine Product
Table 133. Ipca Laboratories Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 134. Ipca Laboratories Recent Development
Table 135. Sichuan Sunny Hope Company Details
Table 136. Sichuan Sunny Hope Business Overview
Table 137. Sichuan Sunny Hope Product
Table 138. Company Description and Business Overview
Table 139. Sichuan Sunny Hope COVID-19 Medicine Product
Table 140. Sichuan Sunny Hope Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 141. Sichuan Sunny Hope Recent Development
Table 142. Zydus Cadila Company Details
Table 143. Zydus Cadila Business Overview
Table 144. Zydus Cadila Product
Table 145. Company Description and Business Overview
Table 146. Zydus Cadila COVID-19 Medicine Product
Table 147. Zydus Cadila Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 148. Zydus Cadila Recent Development
Table 149. Teva Company Details
Table 150. Teva Business Overview
Table 151. Teva Product
Table 152. Company Description and Business Overview
Table 153. Teva COVID-19 Medicine Product
Table 154. Teva Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 155. Teva Recent Development
Table 156. Sun Pharma Company Details
Table 157. Sun Pharma Business Overview
Table 158. Sun Pharma Product
Table 159. Company Description and Business Overview
Table 160. Sun Pharma COVID-19 Medicine Product
Table 161. Sun Pharma Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 162. Sun Pharma Recent Development
Table 163. Rising Pharmaceutical Company Details
Table 164. Rising Pharmaceutical Business Overview
Table 165. Rising Pharmaceutical Product
Table 166. Company Description and Business Overview
Table 167. Rising Pharmaceutical COVID-19 Medicine Product
Table 168. Rising Pharmaceutical Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 169. Rising Pharmaceutical Recent Development
Table 170. KPC Group Company Details
Table 171. KPC Group Business Overview
Table 172. KPC Group Product
Table 173. Company Description and Business Overview
Table 174. KPC Group COVID-19 Medicine Product
Table 175. KPC Group Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 176. KPC Group Recent Development
Table 177. Bristol Laboratories Company Details
Table 178. Bristol Laboratories Business Overview
Table 179. Bristol Laboratories Product
Table 180. Company Description and Business Overview
Table 181. Bristol Laboratories COVID-19 Medicine Product
Table 182. Bristol Laboratories Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 183. Bristol Laboratories Recent Development
Table 184. Shanghai Zhongxisanwei Company Details
Table 185. Shanghai Zhongxisanwei Business Overview
Table 186. Shanghai Zhongxisanwei Product
Table 187. Company Description and Business Overview
Table 188. Shanghai Zhongxisanwei COVID-19 Medicine Product
Table 189. Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 190. Shanghai Zhongxisanwei Recent Development
Table 191. Shanghai Pharma Company Details
Table 192. Shanghai Pharma Business Overview
Table 193. Shanghai Pharma Product
Table 194. Company Description and Business Overview
Table 195. Shanghai Pharma COVID-19 Medicine Product
Table 196. Shanghai Pharma Revenue in COVID-19 Medicine Business 2019 and 2020 (Million US$)
Table 197. Shanghai Pharma Recent Development
Table 198. Company Description and Business Overview
Table 199. Company Description and Business Overview
Table 200. Company Description and Business Overview
Table 201. Company Description and Business Overview
Table 202. Company Description and Business Overview
Table 203. Company Description and Business Overview
Table 204. Company Description and Business Overview
Table 205. Company Description and Business Overview
Table 206. Company Description and Business Overview
Table 207. Company Description and Business Overview
Table 208. Company Description and Business Overview
Table 209. Company Description and Business Overview
Table 210. Company Description and Business Overview
Table 211. Company Description and Business Overview
Table 212. Company Description and Business Overview
Table 213. Company Description and Business Overview
Table 214. Company Description and Business Overview
Table 215. Company Description and Business Overview
Table 216. Company Description and Business Overview
Table 217. Company Description and Business Overview
Table 218. Company Description and Business Overview
Table 219. Company Description and Business Overview
Table 220. Key Drivers: Impact Analysis (2021-2026)
Table 221. Key Opportunities
Table 222. Key Challenges
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Medicine Market Share by Type: 2020 VS 2026
Figure 2. Tablet Features
Figure 3. Injection Features
Figure 4. Global COVID-19 Medicine Market Share by Application: 2020 VS 2026
Figure 5. Patients With Mild Symptoms Case Studies
Figure 6. Critically Ill Case Studies
Figure 7. Other Case Studies
Figure 8. COVID-19 Medicine Report Years Considered
Figure 9. Global COVID-19 Medicine and Growth Rate (2019-2026) (Million US$)
Figure 10. Global COVID-19 Medicine Market Share by Regions (2019-2026)
Figure 11. Global COVID-19 Medicine Market Share by Players in 2019
Figure 12. Global COVID-19 Medicine Market Size Market Share by Type (2019-2026)
Figure 13. Global COVID-19 Medicine Market Size Market Share by Application (2019-2026)
Figure 14. North America COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 15. Europe COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. China COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. Japan COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Southeast Asia COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. India COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. Central & South America COVID-19 Medicine Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed
  • Global Thermal CTP Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Thermal CTP market size was valued at US$ 337.5 million in 2023. With growing demand in downstream market, the Thermal CTP is forecast to a readjusted size of US$ 335.1 million by 2030 with a CAGR of -0.1% during review period. The research report highlights the growth potential of the global Thermal CTP market. Thermal CTP are expected to show stable growth in the future market. However, product differentiation, reducing cos......
  • Global Track and Trace Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Track and Trace Solutions market size was valued at US$ 2560.2 million in 2023. With growing demand in downstream market, the Track and Trace Solutions is forecast to a readjusted size of US$ 7737.5 million by 2030 with a CAGR of 17.1% during review period. The research report highlights the growth potential of the global Track and Trace Solutions market. Track and Trace Solutions are expected to show stable growth in the fut......
  • Streaming video customer satisfaction metrics 3Q 2023
    Published: 04-Jan-2024        Price: US 3999 Onwards        Pages: 0
    "Almost half of subscribers to the largest streaming services (Netflix, Disney+, Apple TV+ and Amazon Prime Video) are at risk of churning with the next price rise." This data set summarises the most-relevant streaming video customer experience KPIs for major streaming video services operators in 16 countries based on primary research (Analysys Mason's 2023 consumer survey). It provides key metrics that allow for comparison between streaming services, and service tier......
  • Monetisation platforms: worldwide forecast 2023-2028
    Published: 03-Jan-2024        Price: US 7999 Onwards        Pages: 12
    "5G and specifically 3GPP standards will help to drive CSPs' spending on monetisation platforms." This report provides forecasts for communications service provider (CSP) spending on monetisation platforms solutions and related services for 2023–2028. The report also provides recommendations for vendors and CSPs. This forecast report and the accompanying data annex provide: a detailed, 6-year worldwide forecast for sp......
  • Global Track and Trace Solutions Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Track and Trace Solutions market size was valued at USD 2692.9 million in 2023 and is forecast to a readjusted size of USD 7514.9 million by 2030 with a CAGR of 15.8% during review period. In distribution and logistics of many types of products, track and trace or tracking and tracing, concerns a process of determining the current and past locations (and other information) of a unique item or property. Some major pla......
  • Variable Data Printing (VDP) - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 104
    The global Variable Data Printing (VDP) market size is expected to reach US$ 44320 million by 2029, growing at a CAGR of 12.7% from 2023 to 2029. The market is mainly driven by the significant applications of Variable Data Printing (VDP) in various end use industries. The expanding demands from the Consumer Goods, Food & Beverages, Advertising Printing Industry and Manufacturing Industry, are propelling Variable Data Printing (VDP) market. Electrophotographic Printing, one of the segments analys......
  • Spectrum auction tracker 3Q 2023
    Published: 22-Dec-2023        Price: US 25000 Onwards        Pages: 0
    Analysys Mason’s Spectrum auction tracker provides granular, accurate details and analysis of concluded auctions of mobile and fixed wireless spectrum, reaching back to 2005. Data is provided in a fully searchable spreadsheet format, for use as a benchmarking and planning tool, and is updated quarterly.  The information for each concluded auction includes: geographical region, country and date of the auction freque......
  • Pay-TV quarterly metrics 2Q 2023
    Published: 22-Dec-2023        Price: US 1999 Onwards        Pages: 0
    The pay-TV market is changing rapidly as consumer expectations and greater price competition exert pressure. Our quarterly metrics include market shares, access technology splits and quarterly growth figures for 51 countries. Data coverage Each quarter, the following metrics are published for 51 countries and 247 operators: country-level pay-TV connections and household penetration rates country-level breakdown of access technologies, ......
  • Monetisation strategies in the face of Eutelsat OneWeb, Kuiper and Starlink
    Published: 22-Dec-2023        Price: US 4999 Onwards        Pages: 10
    "The growth of NGSO constellations provides opportunities for GEO service providers to refine their offerings and remain relevant and prosperous in the long-term." Geostationary Earth orbit (GEO) satellite operators and service providers are no longer the only option for communications end users, with low-Earth orbit high-throughput satellite (LEO-HTS) constellation demand increasing rapidly. New GEO strategies are required to remain relevant in this new and highly co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs